Short-Term Enzyme Replacement in the Murine Model of Sanfilippo Syndrome Type B
- 31 December 2000
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 71 (4) , 573-580
- https://doi.org/10.1006/mgme.2000.3095
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry diseaseProceedings of the National Academy of Sciences, 2000
- Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding α-N-acetylglucosaminidaseProceedings of the National Academy of Sciences, 1999
- Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypesEuropean Journal of Human Genetics, 1999
- Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.Journal of Clinical Investigation, 1998
- NAGLU Mutations Underlying Sanfilippo Syndrome Type BAmerican Journal of Human Genetics, 1998
- Genotype-Phenotype Correspondence in Sanfilippo Syndrome Type BAmerican Journal of Human Genetics, 1998
- The molecular basis of Sanfilippo syndrome type B.Proceedings of the National Academy of Sciences, 1996
- Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant SourcesAnnals of Internal Medicine, 1995
- Enzyme replacement in a canine model of Hurler syndrome.Proceedings of the National Academy of Sciences, 1994
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991